Cerebrovascular Disease and Statins
Elevated low-density lipoprotein-cholesterol (LDL-C) is a causal factor for the development of atherosclerotic cardiovascular disease (ASCVD); accordingly, LDL-C lowering is associated with a decreased risk of progression of atherosclerotic plaques and development of complications. Currently, statin...
Saved in:
| Main Authors: | Luis M. Beltrán Romero, Antonio J. Vallejo-Vaz, Ovidio Muñiz Grijalvo |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Frontiers Media S.A.
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/8a3d8d1292df457a84358aad93f70458 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Loss of Hepatic Surf4 Depletes Lipid Droplets in the Adrenal Cortex but Does Not Impair Adrenal Hormone Production
by: Xiaole Chang, et al.
Published: (2021) -
Statins in Non-alcoholic Steatohepatitis
by: Jose D. Torres-Peña, et al.
Published: (2021) -
Healthcare Utilization and Statin Re‐Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction
by: John N. Booth, et al.
Published: (2018) -
Enfermedad cerebrovascular y estatinas
by: Prat,Hernán
Published: (2012) -
Statin Therapy in Very Old Patients: Lights and Shadows
by: Lidia Cobos-Palacios, et al.
Published: (2021)